CORC

在结果中检索

CORC

浏览/检索结果: 共13条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Optimal time-point of response assessment was associated with tumour burden in patients with unresectable hepatocellular carcinoma undergoing repeated transarterial chemoembolization 会议论文
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), APR 10-14, 2019
作者:  Xia, Dongdong;  Wang, Enxin;  Wang, Qiuhe;  Bai, Wei;  Wang, Zhexuan
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/31
Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress 会议论文
作者:  Ren, Z.;  Assenat, E.;  Cubillo, A.;  Pluntke, S.;  Rimassa, L.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Radiation-related lymphopenia association with worse prognosis in unresectable hepatocellular carcinoma patients 会议论文
ECCO European Cancer Congress, JAN 27-30, 2017
作者:  Zhao, Q.;  Xu, X.;  Yue, J.;  Yan, H.;  Feng, R.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/31
Global GIDEON data: Subgroup analysis of sorafenib dosing pattern in patients with unresectable hepatocellular carcinoma 会议论文
作者:  Kudo, Masatoshi;  Ye, Sheng-Long;  Nakajima, Keiko;  Lencioni, Riccardo
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/06
Efficacy and Safety of Intensity Modulated Radiation Therapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma 会议论文
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016-10-01
作者:  Zhao, Y.;  Wang, W. H.;  Li, Y. X.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma 会议论文
ANNALS OF ONCOLOGY, 2015-12-01
作者:  Yao, X.;  Yan, D.;  Zeng, H.;  Liu, D.;  Li, H.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04
Combination of transarterial chemoembolization plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup results of the START final analysis 会议论文
作者:  Han, G.;  Yang, J.;  Shao, G.;  Teng, G.;  Wang, M.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19
Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial. 会议论文
作者:  Han, Guohong;  Yang, Jijin;  Shao, Guoliang;  Teng, Gaojun;  Wang, Maoqiang
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial. 会议论文
作者:  Han, Guohong;  Yang, Jijin;  Shao, Guoliang;  Teng, Gaojun;  Wang, Maoqiang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/19
SECOND INTERIM ANALYSIS OF GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN UNRESECTABLE HEPATOCELLULAR CARCINOMA [UHCC] AND OF ITS TREATMENT WITH SORAFENIB): SUBGROUP ANALYSIS BY INITIAL SORAFENIB (SOR) DOSE 会议论文
作者:  Marrero, Jorge A.;  Venook, Alan;  Kudo, Masatoshi;  Ye, Sheng-Long;  Nakajima, Keiko
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace